Hemostatic Agent for Kidney Cancer

The University of Chicago, Chicago, IL
Kidney CancerHemostatic Agent - Device
All Sexes

Study Summary

This trial will determine if using hemostatic agents during robotic partial nephrectomy affects complication rates.

Eligible Conditions
  • Kidney Cancer

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: up to 6 months

up to 6 months
An absolute change in hemoglobin
Operating room parameters
Patients with a hospital stay over 30 days
Safety monitoring parameters: Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Total number of major bleeding complications

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Group 2 (Hemostatic Agents Negative -)
1 of 2
Group 1 (Hemostatic Agents Plus +)
1 of 2

Active Control

Experimental Treatment

178 Total Participants · 2 Treatment Groups

Primary Treatment: Hemostatic Agent · No Placebo Group · N/A

Group 1 (Hemostatic Agents Plus +)
Experimental Group · 1 Intervention: Hemostatic Agent · Intervention Types: Device
Group 2 (Hemostatic Agents Negative -)
ActiveComparator Group · 1 Intervention: No Hemostatic Agent · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 6 months

Who is running the clinical trial?

University of ChicagoLead Sponsor
950 Previous Clinical Trials
759,372 Total Patients Enrolled
Arieh Shalhav, MDPrincipal InvestigatorUniversity of Chicago

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
If you have two kidneys or just one kidney (that is not a transplanted kidney), you can participate.
You may have one or two arteries or veins in your kidney, which is normal.

Frequently Asked Questions

To what extent is enrollment progressing for this clinical research?

"Yes, the clinicaltrials.gov registry indicates that this is an ongoing trial with a start date of January 1st 2016 and most recently edited on June 3rd 2022. Currently, 178 individuals are being sought from one medical centre for participation in this study." - Anonymous Online Contributor

Unverified Answer

Is this medical experiment accepting new participants?

"The clinical trial is accepting applicants, as the data that can be found on clinicaltrials.gov attests to. The study was first put up in January 2016 and recently updated on June 3rd 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.